Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Farooq H Sheikh"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionCardiac sarcoidosis (CS) is an increasingly recognized cause of cardiac disease. Because the clinical presentation of CS is non-specific, the diagnosis is often delayed. Early detection is essential to initiate treatments that reduce the
Externí odkaz:
https://doaj.org/article/bcfc13dafe3b4954bd55c83284cb013f
Autor:
Nicholas Streicher, Leslie Amass, Rong Wang, Jennifer M. Stephens, Traci LeMasters, Rutika Raina, Emma Merrill, Farooq H. Sheikh
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 2, Pp 359-368 (2024)
Abstract Introduction Transthyretin amyloidosis (ATTR) is a progressive, heterogeneous rare disease manifesting as ATTR polyneuropathy (ATTR-PN), ATTR cardiomyopathy (ATTR-CM), or a mixed phenotype. Tafamidis meglumine (20 mg po qd) is approved in so
Externí odkaz:
https://doaj.org/article/c978271c36ae4ea18deac4030ba008bf
From Hip to Heart: A Comprehensive Evaluation of an Infiltrative CardiomyopathyNovel Teaching Points
Autor:
Manavotam Singh, MD, Mrinalini Krishnan, MD, Amre Ghazzal, MD, Marc Halushka, MD, James E. Tozzi, MD, Robert D. Bunning, MD, Maria E. Rodrigo, MD, Samer S. Najjar, MD, Ezequiel J. Molina, MD, Farooq H. Sheikh, MD
Publikováno v:
CJC Open, Vol 3, Iss 11, Pp 1392-1395 (2021)
Infiltrative cardiomyopathies are an increasingly recognized cause of heart failure warranting systematic evaluation. Given overlap of clinical and imaging findings among etiologies of infiltrative cardiomyopathies, comprehensive evaluation, includin
Externí odkaz:
https://doaj.org/article/b144048ac77d45d68bbc1da77ba3c691
Autor:
Anirudh Rao, Manavotam Singh, Mansi Maini, Kelley M. Anderson, Nancy A. Crowell, Paul R. Henderson, Sherry S. Gholami, Farooq H. Sheikh, Samer S. Najjar, Hunter Groninger
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundMany patients with advanced heart failure (HF) are administered chronic intravenous inotropic support (CIIS) as bridge to surgical therapy; some ultimately never receive surgery. We aimed to describe reasons patients “crossover” from CI
Externí odkaz:
https://doaj.org/article/b7a189f9e82c4eeab486c9a4bd5990fb
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 15 (2021)
Left ventricular assist devices (LVAD) are increasingly being used as destination therapy in patients with Stage D heart failure. It has been reported that a majority of patients who receive a durable LVAD (dLVAD) present in cardiogenic shock due to
Externí odkaz:
https://doaj.org/article/612baab150df4911bd444fa7d0d6facb
Autor:
Serena Zampino, Farooq H. Sheikh, Joban Vaishnav, Daniel Judge, Baohan Pan, Amrita Daniel, Emily Brown, Gigi Ebenezer, Michael Polydefkis
Publikováno v:
Neurology. 100:e2036-e2044
Background and ObjectivesHereditary transthyretin amyloidosis (hATTR) is a rare autosomal dominant systemic disease with variable penetrance and heterogeneous clinical presentation. Several effective treatments can reduce mortality and disability, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87bef72ad4fca5527bc29980cf412b49
https://doi.org/10.1212/wnl.0000000000207158
https://doi.org/10.1212/wnl.0000000000207158
Autor:
Michelle M. Kittleson, Frederick L. Ruberg, Amrut V. Ambardekar, Thomas H. Brannagan, Richard K. Cheng, John O. Clarke, Laura M. Dember, Janell Grazzini Frantz, Ray E. Hershberger, Mathew S. Maurer, Jose Nativi-Nicolau, Vaishali Sanchorawala, Farooq H. Sheikh
Publikováno v:
Journal of the American College of Cardiology. 81:1076-1126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94d278695befe6858d6a3558042e3a10
https://doi.org/10.1016/j.jacc.2022.11.022
https://doi.org/10.1016/j.jacc.2022.11.022
Autor:
Mohit Pahuja, Charan Yerasi, Phillip H. Lam, Hayder Hashim, Itsik Ben-Dor, Nelson L. Bernardo, Lowell F. Satler, Farooq H. Sheikh, Samer S. Najjar, Ezequiel J. Molina, Ron Waksman
Publikováno v:
Current Cardiology Reports. 25:213-227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a42c4768b2f71ba66bd4f93753c7a1a5
https://doi.org/10.1007/s11886-023-01843-4
https://doi.org/10.1007/s11886-023-01843-4
Autor:
Jared J. Herr, Farooq H. Sheikh, Parin J. Patel, Anuradha Lala, Christopher V. Chien, Stephanie Hsiao, Ajay Srivastava, Dawn Pedrotty, Jennifer Nowaczyk, Shannon Tompkins, Sara Ahmed, Fei Xiang, Stephen Forest, Michael Z. Tong, Forum Kamdar, Benjamin D'Souza, Ashwin Ravichandran
Publikováno v:
The American Journal of Cardiology. 185:46-52
Advanced heart failure (HF) therapies improve survival in patients with stage D HF. We sought to evaluate differences by race/ethnicity and sex in advanced HF therapy referrals and decision-making across a multicenter survey. We performed a retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a2b5e5d31dbae617a089c434411bb30
https://doi.org/10.1016/j.amjcard.2022.09.015
https://doi.org/10.1016/j.amjcard.2022.09.015
Autor:
Mohit Pahuja, Adam Johnson, Ryan Kabir, Sukhdeep Bhogal, Jason P. Wermers, Nelson L. Bernardo, Itsik Ben-Dor, Hayder Hashim, Lowell F. Satler, Farooq H. Sheikh, Ron Waksman
Publikováno v:
Journal of the American College of Cardiology. 80:2028-2049
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a13cb03426741d6c503137c116993c7
https://doi.org/10.1016/j.jacc.2022.08.807
https://doi.org/10.1016/j.jacc.2022.08.807